Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

CARIS SCIENCE INC

Filed by SPLITOAK STRATEGIES LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$40,000.00
Expenses
Not reported
Filing UUID
2cb66f7a-c1a8-412c-b307-ae25f94f9ad8
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; HR 5081, Telehealth Modernization Act, prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act

Literal federal measure citations: HR 5081, HR 5269

HCR · Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.